Chemotherapy for Allogeneic Bone Marrow Transplant Patients

Most patients receive chemotherapy from their oncologist. The type of chemotherapy varies from disease to disease. The more chemotherapy that is given before collecting bone marrow cells, the fewer cancer cells there will be. However, chemotherapy can damage the body as well as increase the toxicity of the transplant. Therefore, the amount of chemotherapy given before transplant should be just enough to get the cancer under control.